The Chief Scientific Advisor at Novo Nordisk, Lotte Bjerre Knudsen, was the key force who pushed hard to develop GLP-1 drugs for treating obesity and subsequently for Alzheimers
doi: 10.1021/ACS.EST.0C02558 90 de LuisDAIzaolaOAllerRArmentiaACullarL
Evaluation of an [(18)F]AlF-NOTA Analog of Exendin-4 for Imaging of GLP-1 Receptor in Insulinoma
High-sugar and processed foods: increase inflammation that creates free radicals in the body and reduce glutathiones effectiveness
GLP-1 medications sit at the opposite, well-studied end
I think were all excited about the benefits of these things in the future, but gosh, I mean, the concept of the fact that you dont even know what youre buying and youre just getting this from a compound pharmacy with no regulation and no oversight, thats the scariest thing, because youre injecting this into your body